
|Articles|July 1, 1998
Supplements and Featured Publications
- New and Emerging Therapies in the Treatment of Hypertension and Congestive Heart Failure
 - Volume 4
 - Issue 7 Suppl
 
New Drug Class Offers Benefits in Heart Failure
Author(s)Edward P. Havranek, MD
Advertisement
Articles in this issue
over 27 years ago
Participating Facultyover 27 years ago
Gene Polymorphism Influences Response to Angiotensin Blockadeover 27 years ago
Exploring the Benefits Beyond Blood Pressure ControlNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
COVID-19 Vaccination Linked to Lower Risk of Long COVID in Adolescents
2
Breast Cancer Dominating Oncology Research, Access Disparities: Gen Li, PhD
3
Nearly All US Youth With BMI-Defined Obesity Have Excess Adiposity
4
Role of MRAs in Heart Failure Treatment
5















































